Researchers at the Cardiovascular Research Center at Icahn School of Medicine at Mount Sinai have successfully tested a powerful gene therapy, delivered directly into the heart, to reverse heart failure in large animal models.The new research study findings, published in Science Translational Medicine, is the final study phase before human clinical trials can begin testing SUMO-1 gene therapy. SUMO-1 is a gene that is "missing in action" in heart failure patients.

Source: http://feedproxy.google.com/~r/mnt/healthnews/~3/btCcivVQNJU/268788.php
sport news news auto sport
No comments:
Post a Comment